La Fondation Prevent Cancer accorde 1 million de TP4T1 en nouvelles subventions de recherche
POUR DIFFUSION IMMÉDIATE
Kyra Meister
kyra.meister@preventcancer.org
703-836-1746
Alexandria, Virginie – La Fondation Prevent Cancer® is pleased to announce new funding for ten scientists who are exploring innovative approaches in artificial intelligence (AI) tools, developing new imaging platforms, addressing health disparities and more. Each scientist has been awarded $100,000 for a two-year period. Areas of focus include brain, breast, cervical, head and neck, kidney, lung, ovarian, prostate, skin (including melanoma), and uterine cancers.
These research projects have been awarded thanks to the generosity of Prevent Cancer Foundation donors. Read on for more on the 2025 research grantees or access more detailed information on their projects.
Bénéficiaire: Tamar Berger, M.D, MHA
Titre du projet: Detection of Molecular Biomarkers for Oral Cancer Prevention
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Instructor in Clinical Investigation
Institution: Rockefeller University, New York, N.Y., The Laboratory of Genome Maintenance
The study will look to identify early genetic changes in the cells lining the mouth of patients with Fanconi anemia (FA) before oral cancer develops (FA puts you at increased risk for oral cancer). If successful, the methods could be applied to other groups at increased risk for cancer—such as people who smoke heavily or patients who have had a bone marrow transplant—expanding cancer prevention efforts and saving lives.
Bénéficiaire: Eric Brouzes, Ph.D.
Titre du projet: Early Cervical Cancer Detection Using a Single Non-invasive Test
Prix nommé : Monalita & Fansly’s Spicy Grant for Cancer Prevention
Position: Professor
Institution: Stony Brook University, New York, N.Y.
Cervical cancer, a highly preventable disease if detected at an early stage, remains one of the leading causes of cancer-related mortality in women worldwide. This project will develop a diagnostic test that is portable and handheld, making it inexpensive and usable in low-resource settings. This innovative approach will identify women with precancer and cancer in a single non-invasive test, having the potential to significantly improve cervical cancer screening rates and contribute to eliminating cervical cancer worldwide.
Bénéficiaire: Jim Hu, M.D., MPH
Titre du projet: Using Technology to Improve Prostate Cancer Screening Information Quality
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Professor
Institution: Weill Medical College of Cornell University, New York, N.Y.
This project aims to evaluate the link between the quality of online information about prostate cancer screening and attitudes toward these screenings. By guiding men to reliable resources, this project will enhance early detection efforts and contribute to reducing prostate cancer mortality among high-risk groups.
Bénéficiaire: Mohammadhadi Khorrami, Ph.D.
Titre du projet: Novel AI Imaging Tools for Early Detection and Invasion of Lung Cancer
Prix nommé : La Fondation caritative de la famille Shure à la mémoire de Max Shure
Position: Instructor
Institution: Emory University, Atlanta, Ga.
Early detection and accurate classification of lung cancer are crucial for patient outcomes. This project aims to enhance early lung cancer detection and classification using advanced artificial intelligence (AI) tools, an innovative technique that can directly contribute to cancer mortality.
Bénéficiaire: Lydia Pace, M.D., MPH
Titre du projet: Racial Differences in Mammography After the 2024 USPSTF Recommendations
Prix nommé : Programme des familles du Congrès
Position: professeur agrégé
Institution: Brigham and Women’s Hospital, Inc., Boston, Mass.
The project will examine the impact of expanded breast cancer screening guidelines on screening and diagnostic imaging among Black women, who have a greater likelihood of dying from breast cancer compared to the general population and need access to timely diagnosis and treatment.
Bénéficiaire: Aditi Sahu, Ph.D.
Titre du projet: Integrating Non-invasive Biomarkers for Early Melanoma Diagnosis
Prix nommé : Fonds commémoratif Vic Fazio
Position: Senior Research Scientist
Institution: Centre de lutte contre le cancer Memorial Sloan Kettering, New York, NY
This project will use a novel, non-invasive approach for biomarker discovery. Biomarkers will be used to develop a statistical risk classifier to identify pigmented lesions with the potential to become melanoma. This approach aims to enable early and accurate melanoma diagnosis while minimizing unnecessary benign biopsies.
Bénéficiaire: Joseph Stember, M.D., Ph.D.
Titre du projet: Inpainting for Early Detection of Brain Tumors on MRI
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Assistant Attending
Institution: Centre de lutte contre le cancer Memorial Sloan Kettering, New York, NY
This project aims to develop an artificial intelligence (AI) tool to detect small brain tumors early in MRI scans, assisting radiologists in identifying cancer sooner. Early detection of brain cancer improves treatment outcomes and survival rates, ultimately saving lives.
Bénéficiaire: Erin Tagai, Ph.D., MPH
Titre du projet: Development of a ChatBot for Patients Receiving Genetic Testing Results
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Maître assistant
Institution: Fox Chase Cancer Center, Philadelphia, Pa.
Genetic testing and cancer risk management can increase cancer prevention for thousands of U.S. adults annually. The proposed study will develop and evaluate a ChatBot intervention to increase patient understanding of genetic testing results, decrease distress for patients and improve patient-provider communication after genetic testing.
Bénéficiaire: Chen Wang, Ph.D.
Titre du projet: Early Detection of Renal Cancer by a Novel Imaging Platform
Prix nommé : Des jeux géniaux réalisés rapidement
Position: Postdoctoral Fellow
Institution: The Board of Regents of the University of Oklahoma, Norman, Okla.
This project proposes to design a novel platform for guiding the biopsy needle when obtaining renal tissue to check for kidney cancer. With different renal tissues/tumors and vessels clearly visualized and automatically differentiated at the needle tip, this proposed imaging platform will improve clinical outcomes for early cancer detection.
Bénéficiaire: Grace Wang, Ph.D.
Titre du projet: Formative Research to Support FQHC Implementation of HPV Test Self Sampling
Prix nommé : Monalita & Fansly’s Spicy Grant for Cancer Prevention
Position: Director of Research
Institution: Moses-Weitzman Health System Inc., Middletown, Conn.
This project seeks to develop materials to help federally qualified health centers adopt human papillomavirus (HPV) test self-sampling. Access to HPV test self-sampling can improve cervical cancer screening rates and early detection in medically underserved communities.
To view all current research grant and fellowship projects driving these key advancements in cancer prevention and early detection, explore the Base de données des récompenses de la Fondation Prevent Cancer.
Are you interested in receiving a Prevent Cancer Foundation research grant? Applications for 2026 grants will open in the spring of 2025. Please sign up here to receive an email notification when applications open.
Are you interested in funding a Prevent Cancer Foundation research grant? Contact Jennifer Niyangoda, Vice President of Development and Marketing, at Jennifer.Niyangoda@preventcancer.org.
###
À propos de la Fondation Prévenir le Cancer®
La Fondation Prévenir le Cancer® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
La Fondation se mobilise pour relever le défi de réduire les décès par cancer de 40% d'ici 2035. Pour y parvenir, nous nous engageons à investir $20 millions dans des technologies innovantes pour détecter le cancer à un stade précoce et faire progresser le dépistage multi-cancer, $10 millions pour étendre le dépistage du cancer et la vaccination. l'accès à des communautés médicalement mal desservies et $10 millions pour informer le public sur les options de dépistage et de vaccination.
For more information, please visit www.preventcancer.org.